Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04801862

Natural History of Clostridioides Difficile Infection

Aim: To investigate if host factors, such as composition and diversity of intestinal microbiota and/or genetic determinants, are associated with a higher risk of recurrence of Clostridioides difficile infection (CDI). To generate a predictive tool based on epidemiological, clinical, genetic and microbiologic variables aimed to identify patients at a higher risk of CDI recurrence in a context of optimized ICD management. Design: Multicenter prospective cohort study. Patients: Older than 18 years patients with CDI diagnosis, made by IDSA criteria, in the participant centers.

Follow-up: A stewarship program aimed to improve CDI management, including early detection of CDI recurrence, will be implemented in the participant centers. Blood samples for genetic testing and stool samples for intestinal microbiome studies will be collected.

Variables and data analysis: The primary outcome variable will be the emergence of CDI recurrence. Potential independent predictors of recurrence, including genetic and microbiological factors, will be assessed. A predictive tool based on independent predictors of recurrence will be built in a development subpopulation. The performance of the model will be assessed by ROC curves, and sensititvity, especificity, as well as negative and positive predictive values will be calculated, both in the development subpopulation and in a validation subset.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hospital Universitario San Juan, Alicante, Spain

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age older than 18 years
  • New episode of Clostridioides difficile infection, based on IDSA criteria.

Exclusion criteria

  • None

Treatment and study plan

Primary outcomes

  1. CDI recurrence

    Time frame: First 8 weeks after end of therapy

    Clostridioides difficile recurrence

  2. CDI reinfection

    Time frame: Between 8 weeks after end of therapy and before 24 weeks

    New episode of Clostridioides difficile infection

Secondary outcomes

  1. Readmission due to CDI infection

    Time frame: During 24 weeks after the end of therapy

    New hospitalization related to new Clostridioides difficile infection episode

Study contacts

Contact information is provided by the study sponsor or research team.

Miguel Rodríguez Fernández

CONTACT

[email protected]

955015895

Nicolás Merchante, MD; PhD

CONTACT

[email protected]

955015895

Sponsors and collaborators

Lead sponsor

Hospital Universitario de Valme

Other

Registry information

Official study title

Clinical, Microbiological and Genetic Factors Associated With Recurrence of Clostridioides Difficile Infection and Development of a Predictive Tool for Recurrence

Important dates

Study start
2021
Primary completion
2029
Study completion
2029
First posted
Mar 17, 2021
Registry last updated
Sep 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.